SCHEMBL876859

SCHEMBL876859

O=C1[CH]CCCC1c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
DDB1 Q16531 1/20 0.42
CRBN Q96SW2 1/20 0.42
CFTR P13569 1/20 0.38
GOPC Q9HD26 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
IGF1R P08069 1/20 0.38
ALOX15 P16050 1/20 0.38
CTRB1 P17538 1/20 0.37
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
CYP19A1 P11511 1/20 0.36
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
CTRC Q99895 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28024665 0.74 TP53 (0.42) TP53TSHRGAA
SCHEMBL28024673 0.74 TP53 (0.42) TP53TSHRGAA
SCHEMBL28024663 0.74 TP53 (0.42) TP53TSHRGAA
SCHEMBL16179411 0.74 TP53 (0.62) TP53L3MBTL1DDB1CRBNCFTR
SCHEMBL6762506 0.74 TP53 (0.62) TP53L3MBTL1DDB1CRBNCFTR
SCHEMBL24102958 0.73 DDB1 (0.43) TP53L3MBTL1DDB1CRBNCFTR
SCHEMBL361599 0.71 DDB1 (0.48) TP53L3MBTL1DDB1CRBNCFTR
SCHEMBL6627769 0.71 TP53 (0.50) TP53L3MBTL1DDB1CRBNCFTR
SCHEMBL963102 0.71 TP53 (0.54) TP53L3MBTL1DDB1CRBNCFTR
SCHEMBL3538429 0.71 TP53 (0.54) TP53L3MBTL1DDB1CRBNCFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2619190-B1 SUBSTITUTED OXADIAZOLE COMPOUNDS AND THEIR USE AS S1P1 AGONISTS BRISTOL MYERS SQUIBB CO (US) 2015-08-12 EP disclosed
EP-2619190-A1 SUBSTITUTED OXADIAZOLE COMPOUNDS AND THEIR USE AS S1P1 AGONISTS Bristol-Myers Squibb Company (US) 2013-07-31 EP disclosed
WO-2012040532-A1 SUBSTITUTED OXADIAZOLE COMPOUNDS AND THEIR USE AS S1P1 AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-29 WO disclosed